Live long and prosper

14 July 2022

Meet Daniel Ives, co-founder of a Cambridge start-up with one big ambition: to put an end to ageing and the diseases that come with it. 

Read More
3D illustration of mitochondria

Study in mice shows potential for gene-editing to tackle mitochondrial disorders

08 February 2022

Defective mitochondria – the ‘batteries’ that power the cells of our bodies – could in future be repaired using gene-editing techniques. Scientists at the University of Cambridge have shown that it is possible to modify the mitochondrial genome in live mice, paving the way for new treatments for incurable mitochondrial disorders.

Read More
Neurons

Heal thyself

24 May 2021

Three companies, Astex Pharmaceuticals, Eisai Ltd and Eli Lilly and Company, are joining forces with research scientists across Cambridge to explore promising new approaches to the treatment of neurodegenerative disease.

Read More

Pages